Sequegenics

Sequegenics is a private biotechnology and health technology company developing an AI-powered multi-omics platform for genomic analysis. The company combines long-read DNA sequencing, long-read RNA sequencing, proteomics, and cloud-based analytics to detect structural variants and other complex genomic signals that may be missed by conventional short-read workflows. Its offerings appear oriented toward research, translational medicine, and clinical/diagnostic applications rather than a traditional therapeutic drug pipeline. The company has roots in technology first developed in the Emory Vaccine Center and has received non-dilutive grant support and accelerator backing. Overall, Sequegenics is best characterized as a genomics tools and analytics company focused on enabling higher-resolution biological insight for precision medicine and target discovery.